4526 Stock Overview
Engages in the food ingredient, food improving agents, health care, consumer and commercial foods, and chemical improving agents, and vitamins businesses in Japan. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4526 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Riken Vitamin Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,408.00 |
52 Week High | JP¥2,879.00 |
52 Week Low | JP¥2,186.00 |
Beta | -0.19 |
1 Month Change | -4.67% |
3 Month Change | -7.99% |
1 Year Change | 8.91% |
3 Year Change | 41.90% |
5 Year Change | 14.94% |
Change since IPO | 44.19% |
Recent News & Updates
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality
Nov 21Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50
Aug 28Recent updates
Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality
Nov 21Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50
Aug 28Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50
Aug 13Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50
Jul 26Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50
Jul 11Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations
May 21Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50
Mar 15Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50
Mar 01Shareholder Returns
4526 | JP Food | JP Market | |
---|---|---|---|
7D | -3.1% | -1.2% | -0.9% |
1Y | 8.9% | 6.6% | 13.7% |
Return vs Industry: 4526 exceeded the JP Food industry which returned 6.6% over the past year.
Return vs Market: 4526 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
4526 volatility | |
---|---|
4526 Average Weekly Movement | 2.7% |
Food Industry Average Movement | 2.5% |
Market Average Movement | 3.6% |
10% most volatile stocks in JP Market | 7.4% |
10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4526 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4526's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1917 | 1,857 | Kazuhiko Yamaki | www.rikenvitamin.jp |
Riken Vitamin Co., Ltd. engages in the food ingredient, food improving agents, health care, consumer and commercial foods, and chemical improving agents, and vitamins businesses in Japan. It offers dressing, such as non-oil dressings; seaweed; and extract / seasoning, soup, soup stock, retort-packed food, salad-related products, seafood / meat extracts, and cut wakame. The company also provides food improving agents, including food emulsifiers, processed oils, natural colorants, and vitamin E for emulsification, anti-staling, foaming, coagulation, anti-sticking, texture improvement, coloring, nutritional enhancement, and antioxidant to food manufacturers; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidant.
Riken Vitamin Co., Ltd. Fundamentals Summary
4526 fundamental statistics | |
---|---|
Market cap | JP¥74.02b |
Earnings (TTM) | JP¥8.34b |
Revenue (TTM) | JP¥94.02b |
8.8x
P/E Ratio0.8x
P/S RatioIs 4526 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4526 income statement (TTM) | |
---|---|
Revenue | JP¥94.02b |
Cost of Revenue | JP¥62.93b |
Gross Profit | JP¥31.09b |
Other Expenses | JP¥22.74b |
Earnings | JP¥8.34b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 274.81 |
Gross Margin | 33.06% |
Net Profit Margin | 8.87% |
Debt/Equity Ratio | 18.6% |
How did 4526 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield34%
Payout RatioDoes 4526 pay a reliable dividends?
See 4526 dividend history and benchmarksRiken Vitamin dividend dates | |
---|---|
Ex Dividend Date | Mar 28 2025 |
Dividend Pay Date | Jun 10 2025 |
Days until Ex dividend | 98 days |
Days until Dividend pay date | 172 days |
Does 4526 pay a reliable dividends?
See 4526 dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 15:24 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Riken Vitamin Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Company Forecast |
null null | Daiwa Securities Co. Ltd. |
Yumiko Kai | Ichiyoshi Research Institute Inc. |